Publication | Open Access
Glimepiride Versus Metformin as Monotherapy in Pediatric Patients With Type 2 Diabetes
141
Citations
8
References
2007
Year
Glimepiride reduced A1C similarly to metformin with greater weight gain, and there was comparable safety over 24 weeks in the treatment of pediatric subjects with type 2 diabetes.
| Year | Citations | |
|---|---|---|
Page 1
Page 1